Global Somatostatin Analogs Market Report, History and Forecast 2014-2025, Breakdown Data by Manufacturers, Key Regions, Types and Application
SKU ID :QYR-14156186 | Published Date: 30-Apr-2019 | No. of pages: 111Description
TOC
Table of Contents
1 Somatostatin Analogs Market Overview
1.1 Somatostatin Analogs Product Overview
1.2 Somatostatin Analogs Market Segment by Type
1.2.1 Octreotide
1.2.2 Lanreotide
1.2.3 Pasireotide
1.3 Global Somatostatin Analogs Market Size by Type
1.3.1 Global Somatostatin Analogs Sales and Growth by Type
1.3.2 Global Somatostatin Analogs Sales and Market Share by Type (2014-2019)
1.3.3 Global Somatostatin Analogs Revenue and Market Share by Type (2014-2019)
1.3.4 Global Somatostatin Analogs Price by Type (2014-2019)
2 Global Somatostatin Analogs Market Competition by Company
2.1 Global Somatostatin Analogs Sales and Market Share by Company (2014-2019)
2.2 Global Somatostatin Analogs Revenue and Share by Company (2014-2019)
2.3 Global Somatostatin Analogs Price by Company (2014-2019)
2.4 Global Top Players Somatostatin Analogs Manufacturing Base Distribution, Sales Area, Product Types
2.5 Somatostatin Analogs Market Competitive Situation and Trends
2.5.1 Somatostatin Analogs Market Concentration Rate
2.5.2 Global Somatostatin Analogs Market Share of Top 5 and Top 10 Players
2.5.3 Mergers & Acquisitions, Expansion
3 Somatostatin Analogs Company Profiles and Sales Data
3.1 Novartis
3.1.1 Company Basic Information, Manufacturing Base and Competitors
3.1.2 Somatostatin Analogs Product Category, Application and Specification
3.1.3 Novartis Somatostatin Analogs Sales, Revenue, Price and Gross Margin(2014-2019)
3.1.4 Main Business Overview
3.2 Peptron
3.2.1 Company Basic Information, Manufacturing Base and Competitors
3.2.2 Somatostatin Analogs Product Category, Application and Specification
3.2.3 Peptron Somatostatin Analogs Sales, Revenue, Price and Gross Margin(2014-2019)
3.2.4 Main Business Overview
3.3 Chiasma
3.3.1 Company Basic Information, Manufacturing Base and Competitors
3.3.2 Somatostatin Analogs Product Category, Application and Specification
3.3.3 Chiasma Somatostatin Analogs Sales, Revenue, Price and Gross Margin(2014-2019)
3.3.4 Main Business Overview
3.4 Ipsen Biopharmaceutical
3.4.1 Company Basic Information, Manufacturing Base and Competitors
3.4.2 Somatostatin Analogs Product Category, Application and Specification
3.4.3 Ipsen Biopharmaceutical Somatostatin Analogs Sales, Revenue, Price and Gross Margin(2014-2019)
3.4.4 Main Business Overview
4 Somatostatin Analogs Market Status and Outlook by Regions
4.1 Global Market Status and Outlook by Regions
4.1.1 Global Somatostatin Analogs Market Size and CAGR by Regions
4.1.2 North America
4.1.3 Asia-Pacific
4.1.4 Europe
4.1.5 South America
4.1.6 Middle East and Africa
4.2 Global Somatostatin Analogs Sales and Revenue by Regions
4.2.1 Global Somatostatin Analogs Sales and Market Share by Regions (2014-2019)
4.2.2 Global Somatostatin Analogs Revenue and Market Share by Regions (2014-2019)
4.2.3 Global Somatostatin Analogs Sales, Revenue, Price and Gross Margin (2014-2019)
4.3 North America Somatostatin Analogs Sales, Revenue, Price and Gross Margin
4.3.1 United States
4.3.2 Canada
4.3.3 Mexico
4.4 Europe Somatostatin Analogs Sales, Revenue, Price and Gross Margin
4.4.1 Germany
4.4.2 UK
4.4.3 France
4.4.4 Italy
4.4.5 Russia
4.4.6 Turkey
4.5 Asia-Pacific Somatostatin Analogs Sales, Revenue, Price and Gross Margin
4.5.1 China
4.5.2 Japan
4.5.3 Korea
4.5.4 Southeast Asia
4.5.4.1 Indonesia
4.5.4.2 Thailand
4.5.4.3 Malaysia
4.5.4.4 Philippines
4.5.4.5 Vietnam
4.5.5 India
4.5.6 Australia
4.6 South America Somatostatin Analogs Sales, Revenue, Price and Gross Margin
4.6.1 Brazil
4.7 Middle East and Africa Somatostatin Analogs Sales, Revenue, Price and Gross Margin
4.7.1 Egypt
4.7.2 GCC Countries
5 Somatostatin Analogs Application/End Users
5.1 Somatostatin Analogs Segment by Application
5.1.1 Acromegaly
5.1.2 Carcinoid Syndrome
5.1.3 Neuroendocrine Tumor
5.1.4 Cushing Syndrome
5.1.5 Others
5.2 Global Somatostatin Analogs Product Segment by Application
5.2.1 Global Somatostatin Analogs Sales by Application
5.2.2 Global Somatostatin Analogs Sales and Market Share by Application (2014-2019)
6 Global Somatostatin Analogs Market Forecast
6.1 Global Somatostatin Analogs Sales, Revenue Forecast (2019-2025)
6.1.1 Global Somatostatin Analogs Sales and Growth Rate Forecast (2019-2025)
6.1.1 Global Somatostatin Analogs Revenue and Growth Rate Forecast (2019-2025)
6.2 Global Somatostatin Analogs Forecast by Regions
6.2.1 North America Somatostatin Analogs Sales and Revenue Forecast (2019-2025)
6.2.2 Europe Somatostatin Analogs Sales and Revenue Forecast (2019-2025)
6.2.3 Asia-Pacific Somatostatin Analogs Sales and Revenue Forecast (2019-2025)
6.2.3.1 China
6.2.3.2 Japan
6.2.3.3 Korea
6.2.3.4 Southeast Asia
6.2.3.5 India
6.2.3.6 Australia
6.2.4 South America Somatostatin Analogs Sales and Revenue Forecast (2019-2025)
6.2.5 Middle East and Africa Somatostatin Analogs Sales and Revenue Forecast (2019-2025)
6.2.5.1 Egypt
6.2.5.2 GCC Countries
6.3 Somatostatin Analogs Forecast by Type
6.3.1 Global Somatostatin Analogs Sales and Revenue Forecast by Type (2019-2025)
6.3.2 Octreotide Gowth Forecast
6.3.3 Lanreotide Gowth Forecast
6.4 Somatostatin Analogs Forecast by Application
6.4.1 Global Somatostatin Analogs Sales Forecast by Application (2019-2025)
6.4.2 Global Somatostatin Analogs Forecast in Acromegaly
6.4.3 Global Somatostatin Analogs Forecast in Carcinoid Syndrome
7 Somatostatin Analogs Upstream Raw Materials
7.1 Somatostatin Analogs Key Raw Materials
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price
7.1.3 Raw Materials Key Suppliers
7.2 Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Somatostatin Analogs Industrial Chain Analysis
8 Marketing Strategy Analysis, Distributors
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Distributors
8.3 Downstream Customers
9 Research Findings and Conclusion
Appendix
Methodology/Research Approach
Research Programs/Design
Market Size Estimation
Market Breakdown and Data Triangulation
Data Source
Secondary Sources
Primary Sources
Disclaimer
Tables & Figures
List of Tables and Figures
Figure Somatostatin Analogs Product Picture
Figure Global Somatostatin Analogs Revenue (Million USD) Status and Outlook (2014-2025)
Figure Global Somatostatin Analogs Sales (K MT) Status and Outlook (2014-2025)
Figure Product Picture of Octreotide
Table Major Players of Octreotide
Figure Global Octreotide Sales (K MT) and Growth Rate (%)(2014-2018)
Figure Product Picture of Lanreotide
Table Major Players of Lanreotide
Figure Global Lanreotide Sales (K MT) and Growth Rate (%)(2014-2019)
Figure Product Picture of Pasireotide
Table Major Players of Pasireotide
Figure Global Pasireotide Sales (K MT) and Growth Rate (%)(2014-2019)
Table Global Somatostatin Analogs Sales (K MT) and Growth Rate (%) Comparison by Type
Table Global Somatostatin Analogs Sales (K MT) by Type (2014-2019)
Table Global Somatostatin Analogs Sales Share (%) by Type (2014-2019)
Figure Global Somatostatin Analogs Sales Market Share (%) by Type (2014-2019)
Figure Global Somatostatin Analogs Sales Market Share (%) by Type in 2018
Table Global Somatostatin Analogs Revenue (Million USD) by Type (2014-2019)
Table Global Somatostatin Analogs Revenue Share (%) by Type (2014-2019)
Figure Global Somatostatin Analogs Revenue Share (%) by Type (2014-2019)
Figure 2018 Global Somatostatin Analogs Revenue Market Share (%) by Type
Table Global Somatostatin Analogs Price (USD/MT) by Type (2014-2019)
Table Global Somatostatin Analogs Sales (K MT) by Company (2014-2019)
Table Global Somatostatin Analogs Sales Share (%) by Company (2014-2019)
Figure Global Somatostatin Analogs Sales Share (%) by Company in 2018
Table Global Somatostatin Analogs Revenue (Million USD) by Company (2014-2019)
Table Global Somatostatin Analogs Revenue Share (%) by Company (2014-2019)
Figure Global Somatostatin Analogs Revenue Share (%) by Company in 2018
Table Global Market Somatostatin Analogs Average Price (USD/MT) by Company (2014-2019)
Table Global Somatostatin Analogs Top Players Manufacturing Base Distribution and Sales Area
Table Global Somatostatin Analogs Top Players Product Category
Figure Global Somatostatin Analogs Market Share (%) of Top 5 Players
Figure Global Somatostatin Analogs Market Share (%) of Top 10 Players
Table Novartis Basic Information List
Table Novartis Somatostatin Analogs Product Category, Application and Specification
Table Novartis Somatostatin Analogs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2014-2019)
Figure Novartis Somatostatin Analogs Sales Growth Rate (2014-2019)
Figure Novartis Somatostatin Analogs Sales Global Market Share (%)(2014-2019)
Table Peptron Basic Information List
Figure Peptron Somatostatin Analogs Product Category, Application and Specification
Table Peptron Somatostatin Analogs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2014-2019)
Figure Peptron Somatostatin Analogs Sales Growth Rate (2014-2019)
Figure Peptron Somatostatin Analogs Sales Global Market Share (%)(2014-2019)
Table Chiasma Basic Information List
Figure Chiasma Somatostatin Analogs Product Category, Application and Specification
Table Chiasma Somatostatin Analogs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2014-2019)
Figure Chiasma Somatostatin Analogs Sales Growth Rate (2014-2019)
Figure Chiasma Somatostatin Analogs Sales Global Market Share (%)(2014-2019)
Table Ipsen Biopharmaceutical Basic Information List
Figure Ipsen Biopharmaceutical Somatostatin Analogs Product Category, Application and Specification
Table Ipsen Biopharmaceutical Somatostatin Analogs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2014-2019)
Figure Ipsen Biopharmaceutical Somatostatin Analogs Sales Growth Rate (2014-2019)
Figure Ipsen Biopharmaceutical Somatostatin Analogs Sales Global Market Share (%)(2014-2019)
Table Global Somatostatin Analogs Market Size Comparison by Regions (2014-2025)
Figure North America Somatostatin Analogs Revenue (Million USD) and Growth Rate (%)(2014-2025)
Figure Asia-Pacific Somatostatin Analogs Revenue (Million USD) and Growth Rate (%)(2014-2025)
Figure Europe Somatostatin Analogs Revenue (Million USD) and Growth Rate (%)(2014-2025)
Figure South America Somatostatin Analogs Revenue (Million USD) and Growth Rate (%)(2014-2025)
Figure Middle East and Africa Somatostatin Analogs Revenue (Million USD) and Growth Rate (%)(2014-2025)
Table Global Somatostatin Analogs Sales (K MT) by Regions (2014-2019)
Table Global Somatostatin Analogs Sales Market Share (%) by Regions (2014-2019)
Figure Global Somatostatin Analogs Sales Market Share (%) by Regions (2014-2019)
Figure 2018 Global Somatostatin Analogs Sales Market Share (%) by Regions
Table Global Somatostatin Analogs Revenue (Million USD) by Regions (2014-2019)
Table Global Somatostatin Analogs Revenue Market Share (%) by Regions (2014-2019)
Figure Global Somatostatin Analogs Revenue Market Share (%) by Regions (2014-2019)
Figure 2018 Global Somatostatin Analogs Revenue Market Share (%) by Regions
Table Global Somatostatin Analogs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2014-2019)
Figure North America Somatostatin Analogs Sales Growth Rate
Table North America Somatostatin Analogs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2014-2019)
Figure United States Somatostatin Analogs Sales (K MT)(2014-2019)
Figure United States Somatostatin Analogs Revenue (Million USD)(2014-2019)
Figure Canada Somatostatin Analogs Sales (K MT)(2014-2019)
Figure Canada Somatostatin Analogs Revenue (Million USD)(2014-2019)
Figure Mexico Somatostatin Analogs Sales (K MT)(2014-2019)
Figure Mexico Somatostatin Analogs Revenue (Million USD)(2014-2019)
Figure Europe Somatostatin Analogs Sales Growth Rate
Table Europe Somatostatin Analogs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2014-2019)
Figure Germany Somatostatin Analogs Sales (K MT)(2014-2019)
Figure Germany Somatostatin Analogs Revenue (Million USD) (2014-2019)
Figure UK Somatostatin Analogs Sales (K MT)(2014-2019)
Figure UK Somatostatin Analogs Revenue (Million USD)(2014-2019)
Figure France Somatostatin Analogs Sales (K MT)(2014-2019)
Figure France Somatostatin Analogs Revenue (Million USD)(2014-2019)
Figure Italy Somatostatin Analogs Sales (K MT)(2014-2019)
Figure Italy Somatostatin Analogs Revenue (Million USD)(2014-2019)
Figure Russia Somatostatin Analogs Sales (K MT)(2014-2019)
Figure Russia Somatostatin Analogs Revenue (Million USD)(2014-2019)
Figure Turkey Somatostatin Analogs Sales (K MT)(2014-2019)
Figure Turkey Somatostatin Analogs Revenue (Million USD)(2014-2019)
Figure Asia-Pacific Somatostatin Analogs Sales Growth Rate
Table Asia-Pacific Somatostatin Analogs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2014-2019)
Figure China Somatostatin Analogs Sales (K MT)(2014-2019)
Figure China Somatostatin Analogs Revenue (Million USD)(2014-2019)
Figure Japan Somatostatin Analogs Sales (K MT)(2014-2019)
Figure Japan Somatostatin Analogs Revenue (Million USD)(2014-2019)
Figure Korea Somatostatin Analogs Sales (K MT)(2014-2019)
Figure Korea Somatostatin Analogs Revenue (Million USD)(2014-2019)
Figure Southeast Asia Somatostatin Analogs Sales (K MT)(2014-2019)
Figure Southeast Asia Somatostatin Analogs Revenue (Million USD)(2014-2019)
Figure Indonesia Somatostatin Analogs Sales (K MT)(2014-2019)
Figure Indonesia Somatostatin Analogs Revenue (Million USD)(2014-2019)
Figure Thailand Somatostatin Analogs Sales (K MT)(2014-2019)
Figure Thailand Somatostatin Analogs Revenue (Million USD)(2014-2019)
Figure Malaysia Somatostatin Analogs Sales (K MT)(2014-2019)
Figure Malaysia Somatostatin Analogs Revenue (Million USD)(2014-2019)
Figure Philippines Somatostatin Analogs Sales (K MT)(2014-2019)
Figure Philippines Somatostatin Analogs Revenue (Million USD)(2014-2019)
Figure Vietnam Somatostatin Analogs Sales (K MT)(2014-2019)
Figure Vietnam Somatostatin Analogs Revenue (Million USD)(2014-2019)
Figure India Somatostatin Analogs Sales (K MT)(2014-2019)
Figure India Somatostatin Analogs Revenue (Million USD)(2014-2019)
Figure Australia Somatostatin Analogs Sales (K MT)(2014-2019)
Figure Australia Somatostatin Analogs Revenue (Million USD)(2014-2019)
Figure South America Somatostatin Analogs Sales Growth Rate
Table South America Somatostatin Analogs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2014-2019)
Figure Brazil Somatostatin Analogs Sales (K MT)(2014-2019)
Figure Brazil Somatostatin Analogs Revenue (Million USD)(2014-2019)
Figure Middle East and Africa Somatostatin Analogs Sales Growth Rate
Table Middle East and Africa Somatostatin Analogs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2014-2019)
Figure North Africa Somatostatin Analogs Sales (K MT)(2014-2019)
Figure North Africa Somatostatin Analogs Revenue (Million USD)(2014-2019)
Figure GCC Countries Somatostatin Analogs Sales (K MT)(2014-2019)
Figure GCC Countries Somatostatin Analogs Revenue (Million USD)(2014-2019)
Figure Acromegaly Examples
Figure Carcinoid Syndrome Examples
Figure Neuroendocrine Tumor Examples
Figure Cushing Syndrome Examples
Figure Others Examples
Table Global Somatostatin Analogs Sales (K MT) Comparison by Application (2014-2025)
Table Global Somatostatin Analogs Sales (K MT) by Application (2014-2019)
Table Global Somatostatin Analogs Sales Share (%) by Application (2014-2019)
Figure Global Somatostatin Analogs Sales Market Share (%) by Application (2014-2019)
Figure Global Somatostatin Analogs Sales Market Share (%) by Application in 2018
Figure Global Somatostatin Analogs Sales (K MT) and Growth Rate (%) Forecast (2019-2025)
Figure Global Somatostatin Analogs Revenue (Million USD) and Growth Rate (%) Forecast (2019-2025)
Table Global Somatostatin Analogs Sales (K MT) Forecast by Regions (2019-2025)
Figure Global Somatostatin Analogs Sales Market Share (%) Forecast by Regions (2019-2025)
Figure North America Somatostatin Analogs Sales (K MT) and Growth Rate (%) Forecast (2019-2025)
Figure North America Somatostatin Analogs Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Europe Somatostatin Analogs Sales (K MT) and Growth Rate (%) Forecast (2019-2025)
Figure Europe Somatostatin Analogs Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Asia-Pacific Somatostatin Analogs Sales (K MT) and Growth Rate (%) Forecast (2019-2025)
Figure Asia-Pacific Somatostatin Analogs Revenue and Growth Rate (%) Forecast (2019-2025)
Figure China Somatostatin Analogs Sales (K MT) and Growth Rate (%) Forecast (2019-2025)
Figure China Somatostatin Analogs Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Japan Somatostatin Analogs Sales (K MT) and Growth Rate (%) Forecast (2019-2025)
Figure Japan Somatostatin Analogs Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Korea Somatostatin Analogs Sales (K MT) and Growth Rate (%) Forecast (2019-2025)
Figure Korea Somatostatin Analogs Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Southeast Asia Somatostatin Analogs Sales (K MT) and Growth Rate (%) Forecast (2019-2025)
Figure Southeast Asia Somatostatin Analogs Revenue and Growth Rate (%) Forecast (2019-2025)
Figure India Somatostatin Analogs Sales (K MT) and Growth Rate (%) Forecast (2019-2025)
Figure India Somatostatin Analogs Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Australia Somatostatin Analogs Sales (K MT) and Growth Rate (%) Forecast (2019-2025)
Figure Australia Somatostatin Analogs Revenue and Growth Rate (%) Forecast (2019-2025)
Figure South America Somatostatin Analogs Sales (K MT) and Growth Rate (%) Forecast (2019-2025)
Figure South America Somatostatin Analogs Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Middle East and Africa Somatostatin Analogs Sales (K MT) and Growth Rate (%) Forecast (2019-2025)
Figure Middle East and Africa Somatostatin Analogs Revenue and Growth Rate (%) Forecast (2019-2025)
Figure North Africa Somatostatin Analogs Sales (K MT) and Growth Rate (%) Forecast (2019-2025)
Figure North Africa Somatostatin Analogs Revenue and Growth Rate (%) Forecast (2019-2025)
Figure GCC Countries Somatostatin Analogs Sales (K MT) and Growth Rate (%) Forecast (2019-2025)
Figure GCC Countries Somatostatin Analogs Revenue and Growth Rate (%) Forecast (2019-2025)
Table Global Somatostatin Analogs Sales (Million USD) Forecast by Type (2019-2025)
Figure Global Somatostatin Analogs Sales Market Share (%) Forecast by Type (2019-2025)
Table Global Somatostatin Analogs Revenue (Million USD) Forecast by Type (2019-2025)
Figure Global Somatostatin Analogs Revenue Market Share (%) Forecast by Type (2019-2025)
Figure Octreotide Sales Growth Forecast
Figure Lanreotide Sales Growth Forecast
Table Global Somatostatin Analogs Sales (K MT) Forecast by Application (2019-2025)
Figure Global Somatostatin Analogs Sales Forecast by Application (2019-2025)
Figure Global Somatostatin Analogs Sales (K MT) Forecast in Acromegaly
Figure Global Somatostatin Analogs Sales (K MT) Forecast in Carcinoid Syndrome
Table Key Raw Materials Lists
Figure Key Raw Materials Price
Table Raw Materials Key Suppliers Lists
Figure Somatostatin Analogs Manufacturing Cost Structure
Figure Somatostatin Analogs Industrial Chain Analysis
Table Distributors List
Table Somatostatin Analogs Downstream Customers
Companies
Novartis
Peptron
Chiasma
Ipsen Biopharmaceutical
- PRICE
-
$3350$6700$5025Buy Now